NCT03511651

Brief Summary

Although positive end-expiratory pressure (PEEP) has been widely used in mechanical ventilated patients with acute respiratory distress syndrome (ARDS), how to select the "optimal" PEEP is far from consensus. The application of PEEP may result in beneficial effect by recruiting previously collapsed lung areas, harmful effect by over-distending previously aerated lung areas, or a combination of the both. The net effect of PEEP in a certain patient may depend on the recruitability. Because recruitability varies extremely in ARDS patients and strongly correlates with the response to PEEP, estimation of end-expiratory lung volume (EELV) may be essential for individualized setting of PEEP. Whether the FRC changes at different PEEP levels remains unknown.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

April 30, 2018

Completed
2.3 years until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

May 29, 2020

Status Verified

May 1, 2020

Enrollment Period

7 months

First QC Date

April 8, 2018

Last Update Submit

May 28, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • The change of FRC

    EELV measurement by ICU ventilator; PEEP Volume measured through airway release. FRC will be calculated as EELV minus PEEP volume. Correlation between EELV, PEEP volume, FRC at two different PEEP levels are tested by linear regression analysis.

    1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O

Secondary Outcomes (6)

  • The change of PaO2/FiO2 Ratio

    1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O

  • The change of regional EELV

    1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O

  • The change of homogeneity of distribution of tidal volume

    1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O

  • The change of driving Pressure

    1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O

  • The change of regional FRC

    1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O

  • +1 more secondary outcomes

Study Arms (2)

FRC at clinical PEEP level

OTHER

Measuring FRC at clinical PEEP level

Procedure: PEEP

FRC at clinical PEEP + 5cmH2O

EXPERIMENTAL

Increasing PEEP to clinical PEEP + 5cmH2O

Procedure: PEEP

Interventions

PEEPPROCEDURE

Two PEEP levels will be used during mechanical ventilation.

FRC at clinical PEEP + 5cmH2OFRC at clinical PEEP level

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with ARDS according to the Berlin Definition;
  • Age 18-80 years;
  • Ventilated with volume-controlled ventilation using constant flow;
  • Deep sedation (RASS -4 to -5) and absence of spontaneous breathing (i.e., no triggering during tidal breaths and no inspiratory effort during a 5-second end-expiratory hold).

You may not qualify if:

  • Evidence of active air leak from the lung, including bronchopleural fistula, pneumothorax, pneumomediastinum, or existing chest tube;
  • Chest wall and/or abdominal injuries;
  • Evidence suggesting reduced chest wall compliance, such as existing large pleural effusion, thoracic trauma and intra-abdominal hypertension (i.e., intra-abdominal pressure \> 20 mmHg).
  • Presence of pacemaker, defibrillator, and implantable pumps).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jian-Xin Zhou

Beijing, Beijing Municipality, 100050, China

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Jian-Xin Zhou, MD

    Beijing Tiantan Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jian-Xin Zhou, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 8, 2018

First Posted

April 30, 2018

Study Start

August 1, 2020

Primary Completion

February 28, 2021

Study Completion

March 31, 2021

Last Updated

May 29, 2020

Record last verified: 2020-05

Locations